Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Ultrasound contrast agent
Patent
1994-12-21
1996-11-12
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Ultrasound contrast agent
424 95, 424 951, 424673, 12866202, 12866102, 12866101, 514744, 514746, 514752, 514754, 514757, A61K 4902
Patent
active
055737510
ABSTRACT:
Disclosed herein are agents for enhancing the contrast in an ultrasound image. These agents are extremely small bubbles, or "microbubbles," comprised of specially selected gases. The microbubbles described herein exhibit long life spans in solution and may be produced at a size small enough to traverse the lungs, thus enabling improved ultrasound imaging of the cardiovascular system and other vital organs. Also disclosed herein is a method for selecting gases from which contrast agents may be produced. The method is based on calculations using inherent physical properties of gases and describes a means to associate the properties of a gas with the time for dissolution of a microbubble comprised of the gas.
REFERENCES:
patent: 4265251 (1981-05-01), Tichner
patent: 4276885 (1981-07-01), Tichner et al.
patent: 4442843 (1984-04-01), Rasor et al.
patent: 4466442 (1984-08-01), Hilmann et al.
patent: 4533254 (1985-08-01), Cooke et al.
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4572203 (1986-02-01), Feinstein
patent: 4657756 (1987-04-01), Rasor et al.
patent: 4681119 (1987-07-01), Rasor et al.
patent: 4684479 (1987-08-01), D'Arrigo
patent: 4718433 (1988-01-01), Feinstein
patent: 4767610 (1988-08-01), Long
patent: 4774958 (1988-10-01), Feinstein
patent: 4832941 (1989-05-01), Berwing et al.
patent: 4844882 (1989-07-01), Widder et al.
patent: 4859363 (1989-08-01), Davis et al.
patent: 4895876 (1990-01-01), Schweighardt et al.
patent: 4900540 (1990-02-01), Ryan et al.
patent: 4927623 (1990-05-01), Long
patent: 4957656 (1990-09-01), Cerny et al.
patent: 4985550 (1991-01-01), Charpiot et al.
patent: 4987154 (1991-01-01), Long
patent: 4993415 (1991-02-01), Long
patent: 5078146 (1992-01-01), Sato
patent: 5088499 (1992-02-01), Unger
patent: 5107842 (1992-04-01), Levne et al.
patent: 5114703 (1992-05-01), Wolf et al.
patent: 5123414 (1992-06-01), Unger
patent: 5137928 (1992-08-01), Erbel et al.
patent: 5141738 (1992-08-01), Rasor et al.
patent: 5147631 (1992-09-01), Glagch et al.
patent: 5149319 (1992-09-01), Unger
patent: 5155215 (1992-10-01), Ranney
patent: 5171755 (1992-12-01), Kakufman et al.
patent: 5205290 (1993-04-01), Unger
patent: 5209720 (1993-05-01), Unger
patent: 5260496 (1993-11-01), Meinert et al.
patent: 5271928 (1993-12-01), Schneider et al.
patent: 5281408 (1994-01-01), Unger
patent: 5284645 (1994-02-01), Long
patent: 5344393 (1994-09-01), Roth et al.
patent: 5354549 (1994-10-01), Klaveness et al.
patent: 5393524 (1995-02-01), Quay
patent: 5409688 (1995-04-01), Quay
Ophir, J., et al.; Contrast Agents in Diagnostic Ultrasound, Ultrasound in Medicine and Biology, 15:319-333, 1989.
Violante, M. R., et al.; Practice Stabilized Bubbles for Enhanced Organ Ultrasound Imaging, Investigative Radiology, 26:194-200, Nov. 1991.
Mattrey, R. F., et al.; Gas Emulsions as Ultrasound Contrast Agents. Preliminary results in rabbits and dogs. Investigative Radiology, 29:S139-141 (Jun. 1994).
Swanson, Dennis P., et al.; Pharmaceuticals in Medical Imaging, Radiopaque Contrast Media, Radiopharmaceuticals, Enhancement Agents for Magnetic Resonance Imaging and Ultrasound; Macmillan Publishing Co., Chapter 22, pp. 682-685, (1990).
Meltzer, Richard S., et al.; Why Do Lungs Clear Ultrasonic Contrast?, Ultrasound in Medicine and Biology, vol. 6, pp. 263-269, Pergamon Press Ltd., 1980. Printed in Great Britain.
Meltzer, Richard S., et al.; Transmission of Ultrasonic Contrast Through the Lungs, Ultrasound in Medicine and Biology, vol. 7, No. 4, pp. 377-384, 1981. Printed in Great Britain.
American Heart Association, Abstracts of the 58th Scientific Sessions, Circulation 72:Oct. 1985 III-427.
Association of University Radiologists Proceedings of Annual Meeting, Journal of Clinical and Laboratory Research Investigative Radiology 17:4 Abstract 110 1982.
Bleeker, H.; et al., On the Application of Ultrasonic Contrast Agents for Blood Flowmetry and Assessment of Cardiac Perfusion. Journal of Ultrasound in Medicine 9:461-471, 1990.
Bleeker, H.; et al., Ultrasonic Characterization of Albunex, A New Contrast Agent. Journal Acoustical Society of America 87:1792-1797 1990.
Davis, P. L.; et al., Echogenicity Cause by Stable Microbubbles in a Protein-Lipid Emulsion. The Journal of Clinical Ultrasound 9:249-252, Jun. 1981.
De Jong, N.; Hoff, L.; Skotland, T.; Bom, N., Absorption and Scatter of Encapsulated Gas Filled Microspheres: Theoretical Considerations and Some Measurements. Ultrasonics 30:95-103, 1992.
De Jong, N.; Ten Cate, F. J.; Lanc ee, C. T.; Roelandt, J. R. T. C.; Bom, N., Principles and Recent Developments in Ultrasound Contrast Agents. Ultrasonics 29:324-330, Jul. 1991.
Epstein, P. S.; Plesset, M. S., On the Stability of Gas Bubbles in Liquid-Gas Solutions. Journal of Chemical Physics 18:1505-1509, Nov. 1950.
Feinstein, Steven B.; et al., Microcardial Contrast Echocardiography: Examination of Infracoronary Injections. Microbubble Diameters and Video Intensity Decay. American Journal of Physiologic Imaging 1:12-18, 1986.
Feinstein, Steven B.; et al., Safety and Efficacy of a New Transpulmonary Ultrasound Contrast Agent: Initial Multicenter Clinical Results. Journal of American College of Cardiology 16:316-24, Aug. 1990.
Fobbe, V. F.; et al., Farbkodierte Duplexsonographie Und Ultraschallkontrastmittel-Nachweis Von Renalen Perfusionsdefekten Im Tierexperiment. Fortschr. R ontgenstr. 154:242-245, 1991.
Handa, T.; et al., Phospholipid Monolayers at the Triolein-Saline Interface: Production of Microemulsion Particles and Conversion of Monolayers to Bilayers. Biochemistry 29:2884-2890, 1990.
Kabalnov, A. S.; et al., Safety and Efficacy of a New Transpulmonary Ultrasound Contrast Agent: Initial Multicenter Clinical Results. Journal of Fluorine Chemistry 50:271-284, 1990.
Keller, M. W.; et al., Successful Left Ventricular Opacification Following Peripheral Venou Injection of Sonicated Contrast Agent: An Experimental Evaluation. American Heart Journal :570-575, Sep. 1987.
Long, David M. Jr.; et al., Experiments with Radiopaque Perfluorocarbon Emulsions for Selective Opacification of Organs and Total Body Angiography. Investigative Radiology 15:242-247, 1980.
Marshall, Nissim, Encyclodedie Des Gaz. Encyclopedia of Gas, 1976.
Mattrey, Robert F.; et al., Perfluorctylbromide: A Liver/Spleen-Specific and Tumor-Imaging Ultrasound Contrast Material. Radiology 145:759-762, Dec. 1982.
Meltzer, Richard S.; Tickner, E. Glen; Popp, Richard L., Why do the Lungs Clear Ultrasonic Contrast? Ultrasound in Medicine and Biology 6:263-269, 1980.
Ohta, T.; et al., Effect of the Contrast Agent and the Agitation Method on the Size, Number and Stability of Microbubbles: A Basic Experiment for the Myocardial Contrast Study. Japanese Journal of Medical Ultrasonics 18:318-325, 1991.
Schlief, R., Ultrasound Contrast Agents. Current Opinion in Radiology 3:198-207, 1991.
Serratrice, G.; et al., Co-Solubilisation de Fluorocarbures et d'Eau en Pr esence de Nouveaux Tensioactifs Non Ioniques Fluor es. Journal Chim. Phys. 87:1969-1980, 1990.
Sz onyi, F.; et al., Syntheses de Tensioactifs F-Alkyles Non Ioniques Monodisperses. Journal of Fluorine Chemistry 36:195-209, 1987.
Verescon, Christian; et al., An Easy, Convenient Way of Describing the Stability of Fluorocarbon Emulsions. Journal de Chimie Physique 86:2111-2116, 1989.
Widder, Donald J.; et al., Microbubbles as a Contrast Agent for Neurosonography and Ultrasound-Guided Catheter Manipulation: In Vitro Studies. AJR 147:347-352, Aug. 1986.
Zarif, Leila; et al., Synergistic Stabilization of Perfluorocarbon-Pluronic F-68 Emulsion by Perfluoroalkylated Polyhydroxylated Surfactants. JAOCKS 66:10, Oct. 1989.
Ziskin, Marvin C.; et al., Contrast Agents for Diagnostic Ultrasound. Investigative Radiology 6:500-505, 1972.
Kumar Shailendra
Sonus Pharmaceuticals Inc.
LandOfFree
Persistent gaseous bubbles as ultrasound contrast media does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Persistent gaseous bubbles as ultrasound contrast media, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Persistent gaseous bubbles as ultrasound contrast media will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-560518